- Home
- OPTT vs CRVO Comparison
OPTT vs CRVO Comparison
Compare OPTT & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTT
- CRVO
- Stock Information
- Founded
- OPTT 1984
- CRVO 2001
- Country
- OPTT United States
- CRVO United States
- Employees
- OPTT N/A
- CRVO N/A
- Industry
- OPTT Electric Utilities: Central
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- OPTT Utilities
- CRVO Health Care
- Exchange
- OPTT Nasdaq
- CRVO Nasdaq
- Market Cap
- OPTT 74.2M
- CRVO 71.1M
- IPO Year
- OPTT 2007
- CRVO N/A
- Fundamental
- Price
- OPTT $0.43
- CRVO $9.65
- Analyst Decision
- OPTT Strong Buy
- CRVO Strong Buy
- Analyst Count
- OPTT 1
- CRVO 6
- Target Price
- OPTT $1.50
- CRVO $21.50
- AVG Volume (30 Days)
- OPTT 4.0M
- CRVO 78.7K
- Earning Date
- OPTT 12-15-2025
- CRVO 11-10-2025
- Dividend Yield
- OPTT N/A
- CRVO N/A
- EPS Growth
- OPTT N/A
- CRVO N/A
- EPS
- OPTT N/A
- CRVO N/A
- Revenue
- OPTT $5,742,000.00
- CRVO $6,159,786.00
- Revenue This Year
- OPTT $194,798.48
- CRVO N/A
- Revenue Next Year
- OPTT $74.62
- CRVO N/A
- P/E Ratio
- OPTT N/A
- CRVO N/A
- Revenue Growth
- OPTT 3.38
- CRVO N/A
- 52 Week Low
- OPTT $0.17
- CRVO $1.80
- 52 Week High
- OPTT $1.75
- CRVO $16.94
- Technical
- Relative Strength Index (RSI)
- OPTT 45.40
- CRVO 73.54
- Support Level
- OPTT $0.37
- CRVO $8.50
- Resistance Level
- OPTT $0.46
- CRVO $9.45
- Average True Range (ATR)
- OPTT 0.03
- CRVO 0.60
- MACD
- OPTT 0.00
- CRVO 0.28
- Stochastic Oscillator
- OPTT 62.97
- CRVO 99.35
About OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.